ERBB2 and breast cancer: Our research extends UVMR and MVMR analyses to evaluate overall BC, which included Luminal A, Luminal B, HER2-positive, and TNBC, in relation to both malignant and benign thyroid neoplasms, enhancing the understanding of the genetic underpinnings of these diseases.